Humoral immunity is critical for the clearance of pathogens and is the basis for protection elicited by vaccines. An effector subset of CD4 + regulatory T cells (T reg cells) called 'follicular regulatory T cells' (T FR cells) has been identified. T FR cells migrate to the B cell follicle and inhibit antibody production [1] [2] [3] [4] 9 . These signals strongly activate the B cell, which then cycles between the light zone and dark zone of the GC during affinity maturation 6 . The GC B cell simultaneously supplies antigenic signals and costimulation to T FH cells through B7-1, B7-2 and ICOSL 10,11 . The culmination of this interaction is class-switch recombination (CSR), somatic hypermutation and the differentiation of GC B cells into plasma cells that produce large quantities of high-affinity antibodies.
Humoral immunity is critical for the clearance of pathogens and is the basis for protection elicited by vaccines. An effector subset of CD4 + regulatory T cells (T reg cells) called 'follicular regulatory T cells' (T FR cells) has been identified. T FR cells migrate to the B cell follicle and inhibit antibody production [1] [2] [3] [4] . T FR cells express the chemokine receptor CXCR5 and the transcription factors Bcl6 and Foxp3 and have high surface expression of the costimulator ICOS and the co-inhibitor PD-1 (ref. 2) . Follicular helper T cells (T FH cells) also have high expression of CXCR5, ICOS, Bcl6 and PD-1 (but not Foxp3) but stimulate antibody responses 5 . Notably, the ratio of T FH cells to T FR cells can be used to functionally predict the magnitude of antibody responses in a wide range of disease states in mice and humans 2 . How T FR cells modulate antibody responses is still largely unknown.
Antibody responses originate in germinal centers (GCs), highly specialized structures within the B cell follicle in which B cells become activated and differentiate to become effector B cells, plasma cells and memory B cells 6, 7 . The GC reaction is a highly regulated process that depends on T FH cells. T FH cells interact with cognate GC B cells in a process called 'linked recognition' 8 . T FH cells supply key cytokines, such as IL-4 and IL-21, as well as costimulatory molecules, such as CD40L, to the B cell 9 . These signals strongly activate the B cell, which then cycles between the light zone and dark zone of the GC during affinity maturation 6 . The GC B cell simultaneously supplies antigenic signals and costimulation to T FH cells through B7-1, B7-2 and ICOSL 10, 11 . The culmination of this interaction is class-switch recombination (CSR), somatic hypermutation and the differentiation of GC B cells into plasma cells that produce large quantities of high-affinity antibodies.
In contrast to T FH cells, T FR cells inhibit the GC reaction. The mechanisms by which T FR cells exert their inhibitory effects are only beginning to be understood 2 . T FR cells suppress the production of IL-21 and IL-4 by T FH cells and inhibit CSR and antibody production by B cells 3, 4, 12, 13 . CTLA-4 expressed by T FR cells is an important mediator of the suppressive function of T FR cells, since T FR cells lacking CTLA-4 have a substantially diminished ability to suppress antibody production by B cells 14, 15 . In contrast, PD-1 deficiency on T FR cells results in a heightened suppressive ability 13 .
Here we found that T FR cells induced a distinct suppressive state in T FH cells and B cells in which effector molecules and metabolic pathways were suppressed but global effector programs were maintained. We also found that IL-21 was able to overcome T FR cell-mediated suppression by enhancing B cell metabolism and inhibiting T FR cells. These data provide mechanistic insight into how T FR Fig. 1a,b) . We measured robust upregulation of expression of the GC B cell marker GL7 on B cells and CSR to IgG1 and substantial quantities of secreted IgG for B cells cultured with T FH cells alone (Fig. 1a) . When T FR cells were added, CSR, GL7 expression and secretion of antibody were diminished (Fig. 1a) . CD4 + CXCR5 − ICOS − Foxp3 + T reg cells were not able to suppress as efficiently as T FR cells did (Fig. 1b) , as previously reported 12 . T FR cells also suppressed CSR of B cells in response to specific antigen ( Supplementary Fig. 1c) . Furthermore, the suppression of CSR by T FR cells required cell contact, as supernatant from T FR cultures did not suppress B cells (Fig. 1c) . Time-lapse microscopy of cultures revealed that T FR cells closely interacted with both T FH cells and B cells ( Fig. 1d and Supplementary Video 1) . These data suggested that T FR cells might physically disrupt T FH cell-and B cell-linked recognition during suppression 2, 17 . Therefore, our culture system was a robust model for studying synchronized T FR cell-mediated suppression of T FH cells and B cells.
We first investigated whether T FR cells prevent the initial activation of B cells by assessing dilution of the dye CellTrace Violet by B cells to measure their proliferation. Despite a decrease in the number of cell divisions, most B cells proliferated at least one cell cycle when T FR cells were present (Fig. 1e) . T FR cells did not inhibit the proliferation of B cells in co-cultures of only T FR cells and B cells (without T FH cells) and lipopolysaccharide plus IL-4 ( Fig. 1f) . We also analyzed expression of the activation marker CD69 and found that this was upregulated in B cells whether T FR cells were present or not (Fig. 1g) . Studies with fluorescein isothiocyanate-zVAD, a fluorescent reagent that binds active caspase, revealed that T FR cells did not enhance the apoptosis of B cells as a means of suppression (Fig. 1h) . These data demonstrated that early activation of B cells still occurred even in the presence of T FR cells.
To determine if T FR cells alter somatic hypermutation, we performed our in vitro suppression assay with NP-OVA. We found a low frequency of mutations in B cells cultured with T FH cells and that T FR cells diminished somatic hypermutation in B cells (Fig. 1i) . T FR cells (but not T reg cells) also suppressed the activation of T FH cells, as indicated by reduced expression of Bcl6 and the proliferation marker Ki67 (Fig. 1j) . Together these data demonstrated that T FR cells allowed initial activation of B cells but suppressed downstream effector responses, including CSR and antibody production. Fig. 2a,b) . Principal-component analysis demonstrated modest separation of activated B cells from suppressed B cells but no separation of activated T FH cells from suppressed T FH cells (Fig. 2a) . We identified 1,171 genes that were expressed differentially (false-discovery rate (FDR)-adjusted P value, <0.05) by activated B cells relative to their expression in suppressed B cells, and 407 that were expressed differentially by activated T FH cells relative to their expression in suppressed T FH cells ( Fig. 2b and Supplementary Fig. 2c-e) .
We next investigated whether suppression by T FR cells alters T FH cell identity. We compiled a curated list of 'T FH cell genes' encoding regulators of the differentiation and/or function of T FH cells. The expression of many such genes, including those encoding the essential T FH cell transcription factors Bcl6, Ascl2 and Tcf1 (encoded by Tcf7), was not attenuated during T FR cell-mediated suppression (Fig. 2c) . Prdm1 (which encodes Blimp-1, a transcription factor that inhibits T FH cell differentiation) was attenuated during T FR cell-mediated suppression (Fig. 2c) . The expression of Bcl6 and Cxcr5 was slightly elevated in T FH cells after suppression (Fig. 2c) . In contrast, expression of Il4 and Il21 was markedly reduced in T FH cells during T FR cell-mediated suppression (Fig. 2c) , consistent with published findings 12 . These data suggested that suppressed T FH cells still retained their T FH cell program and either failed to upregulate, or actively downregulated, the expression of specific effector molecules. To confirm that the suppressed T FH cells still maintained a T FH cell transcriptional program, we performed single-sample gene-set-enrichment analysis (GSEA) with transcriptional signatures of T FH cells 18 . Suppressed T FH cells qualitatively retained their T FH cell-like transcriptional signature (Fig. 2d) (Fig. 2e) . Therefore, the suppression of T FH cells by T FR cells resulted in a unique suppressed state that did not strongly resemble anergy or exhaustion. Next we investigated whether B cells retained their effector program during suppression by T FR cells. We found lower expression of Ighg1, Ighg2c and Igha by B cells after suppression by T FR cells (Fig. 2f,g ). Ighg2b transcripts were more abundant after such suppression (Fig. 2f,g ); however, IgG2b was not increased at the protein level (data not shown). Three of the 'B cell genes' (which encode products involved in B cell function) most attenuated in B cells suppressed by T FR cells were Pou2af1 (which encodes a transcription factor essential for GC B cell formation 19 ), Xbp1 (which encodes a transcription factor important for the secretion of antibody 20 ) and Aicda (which encodes the cytidine deaminase AID, the enzyme responsible for initiating CSR 21, 22 ) (Fig. 2f,g ). Pax5, Bach2 and Irf8, genes downregulated after B cells differentiate into plasma cells 23, 24 , had higher expression in B cells after suppression by T FR cells (Fig. 2f,g ), which suggested that T FR cells might prevent such differentiation. However, Mxd4, which has high expression in plasma cells, was upregulated in suppressed B cells 23 (Fig. 2f,g ). These data suggested that the gene-expression signature of suppressed B cells was more complex than inhibition of B cell subset differentiation.
Additional comparative analysis of activated and suppressed B cells revealed that suppressed B cells still retained their GC B cell signature (Fig. 2h) . Moreover, suppressed B cells did not show enrichment for exhaustion signatures (NES = −0.69; FDR = 0.994), senescence signatures (NES = 1.05; FDR = 0.561) or anergy signatures (NES = 1.27; FDR = 0.837) (Fig. 2i) . Together these data indicated that B cells and T FH cells maintained their transcriptional signature when suppressed by T FR cells but that the expression of specific effector molecules was actively downregulated.
We next used GSEA to determine if any non-effectorsubset-related pathways were altered in B cells and T FH cells during suppression by T FR cells. Activated B cells showed substantial enrichment for the expression of sets of genes that are targets of the oncoprotein Myc or that encode products involved in signaling via the metabolic checkpoint kinase complex MTORc1, oxidative phosphorylation and glycolysis, relative to the expression of these genes in suppressed B cells (Supplementary Table 1 ). Activated T FH cells also showed enrichment for the expression of genes that are targets of the transcription factor E2F or that encode products involved in A r t i c l e s glycolysis and signaling via MTORc1, relative to the expression of these genes in suppressed T FH cells; however, this enrichment was not as strong as that in B cells (Supplementary Table 1 ). Thus, suppression by T FR cells led to substantial changes in pathways associated with metabolism in B cells and T FH cells.
Suppression by T FR cells alters B cell Myc and mTOR pathways
We next investigated whether the Myc pathway was altered in B cells suppressed by T FR cells, since genes that are targets of Myc were one of the gene sets whose expression was most attenuated in suppressed B cells (NES = 2.77; FDR<0.0001), and Myc has roles in metabolism 25 and is essential for GC reactions 26, 27 . In B cells, most genes that are targets of Myc showed lower expression during suppression by T FR cells (Fig. 3a) (Fig. 3b,c) . We also investigated whether overexpression of Myc would result in the resistance of B cells to suppression by T FR cells. We obtained B cells Fig. 2 ) or loci with evidence of chromatin inaccessibility in the corresponding comparison (right; by ATAC-seq), and the overlap of those two gene sets (middle). (g) RNAseq analysis of transcripts with lower expression in suppressed B cells that also showed less accessibility by ATAC-seq analysis (red denotes genes shown in more detail in the panels that follow). (h-j) ATAC-seq peaks and ChIA-pet annotated B cell regulome gene tracks 33 for Aicda (h), Myc (i) and Pou2af1 (j); red boxes indicate significant downregulation (P < 0.05). (k) Distance of ATAC-seq peaks from TSSs for all peaks or peaks less accessible in suppressed B cells (key). *P < 0.05, **P < 0.01 and ***P < 0.001 (one-way ANOVA with Tukey's correction). Data are pooled from ten independent experiments, each with cells pooled from 20 mice (a-e; mean + s.e.m. in b,c,e), or are representative of two independent experiments (f-k).
A 29 ) and cultured them with T FH and T FR cells. Overexpression of Myc did not restore CSR or antibody secretion (Fig. 3d,e) . However, GL7 expression in B cells was partially restored by Myc overexpression (Fig. 3d) , which suggested that overexpression of Myc might prevent some minor aspects of the suppression of B cells by T FR cells.
Since we found lower expression of components of the mTORc1 pathway in B cells and T FH cells during suppression by T FR cells (Fig. 3f and Supplementary Table 1 ) and the mTOR pathway promotes protein synthesis during activation and has been linked to the enhancement of cellular metabolism 30 , we also investigated whether blocking mTOR would suppress antibody production. We cultured B cells and T FH cells with either the mTORc1 inhibitor rapamycin or T FR cells. Rapamycin potently diminished CSR and antibody production to a degree similar to that achieved with T FR cells (Fig. 3g,h) . The mTORc1-mTORc2 inhibitor PP242 similarly reduced CSR and antibody production (Fig. 3i,j) . Therefore, inhibiting the mTOR pathway suppressed B cell responses to a degree similar to that achieved with T FR cells.
Suppression of B cell metabolism by T FR cells
Since our GSEA revealed that the expression of genes encoding products associated with the glycolysis, oxidative-phosphorylation, and the Myc and mTOR pathways was lower in B cells suppressed by T FR cells, we further analyzed metabolic alterations in such cells. The expression of genes encoding products involved in various metabolic pathways, including serine biosynthesis, purine metabolism, one-carbon metabolism, the tricarboxylic acid cycle and glycolysis, as well as subunits of the mitochondrial electron-transport chain, was lower in suppressed B cells than in activated B cells (Fig. 4a and Supplementary Figs. 3  and 4) . This suggested that central metabolic and anabolic pathways were defective in B cells suppressed by T FR cells.
We assessed the effects of suppression by T FR cells on glycolysis, since this pathway is essential for antibody production 31 . We first compared expression of the glucose transporter Glut1 in B cells suppressed by T FR cells. T FR cells (but not T reg cells) suppressed Glut1 expression in B cells (Fig. 4b) , which suggested that the T FR cells suppressed B cell glycolysis. The suppression of Glut1 expression (and CSR) in B cells by T FR cells was not due to an increase in the abundance of non-dividing cells (which have low expression of Glut1), because comparison of B cells that had undergone the same number of cell divisions revealed diminished Glut1 expression and CSR in the suppressed B cells (Fig. 4c and Supplementary Fig. 5 ). In addition, the suppression of CSR and metabolism by T FR cells occurred before the changes in B cell proliferation; when we analyzed B cells that had been added to activated or suppressed cultures and harvested 20 h later (before the first cell division), B cells in suppressed cultures had lower expression of Glut1 and IgG1 than that of B cells in activated cultures (Fig. 4d and Supplementary Fig. 5 ). These studies indicated a decoupling of CSR and metabolism from proliferation and demonstrated that the suppression of CSR and metabolism in B cells by T FR cells could occur independently of changes in proliferation. T FR cells (but not T reg cells) also caused lower expression of Glut1 in T FH cells (Fig. 4e) .
We next analyzed glucose uptake, as measured by glucose in the culture supernatants. Glucose use was much lower in cultures containing T FR cells than in cultures without T FR cells (Fig. 4f) . We also measured lactate production, since a large fraction of glucose-derived carbon is secreted from cells in the form of lactate. Lactate production was also much lower in cultures with T FR cells than in cultures without T FR cells (Fig. 4g) . We next investigated whether inhibiting glycolysis could recapitulate the effects of suppression by T FR cells. We cultured B cells and T FH cells with 2-deoxyglucose (2DG), a glucose analog that inhibits glycolysis. 2DG robustly suppressed antibody production, similar to results obtained by the suppression of B cells by T FR cells (Fig. 4h,i) . In addition, glutaminolysis was lower in the presence of T FR cells than in their absence, and inhibition of glutaminolysis resulted in diminished antibody production (Supplementary Fig. 5) .
Since one-carbon, serine and purine metabolism were attenuated during T FR cell-mediated suppression, we assessed these pathways in more detail. In proliferating cells, the folate-mediated onecarbon metabolism pathway catabolizes serine to generate one-carbon units (10-formyl tetrahydrofolate) for de novo purine biosynthesis. The expression of all genes encoding enzymes involved in onecarbon metabolism and the serine-biosynthetic pathway was significantly lower in suppressed B cells than in activated B cells (Fig. 4j  and Supplementary Fig. 3) . Reduced expression of genes encoding products involved in one-carbon metabolism in B cells suppressed by T FR cells was not due to altered proliferation, because the expression of Shmt1 and Shmt2 (a cytosolic enzyme and mitochondrial enzyme, respectively, in one-carbon metabolism that are upregulated within hours of lymphocyte activation 32 ) were attenuated before the first cell division (Fig. 4k) . Next we sought to determine whether inhibitors of purine metabolism could recapitulate suppression by T FR cells. Methotrexate (an inhibitor that targets Dhfr, an enzyme essential for purine biosynthesis) or azathioprine (a purine analog) robustly suppressed antibody production when added to cultures of B cells and T FH cells (Fig. 4l,m) . These data demonstrated that the T FR cells suppressed multiple metabolic pathways in B cells and that inhibiting these pathways was able to recapitulate the suppression of antibody production by T FR cells. Fig. 6 ). We compared B cells from those secondary cultures with B cells from primary cultures (Fig. 5a) . T FH cells cultured with suppressed B cells in the secondary cultures had much higher co-expression of Ki67 and Bcl6 than that of T FH cells cultured with B cells and T FR cells in the primary cultures and were more numerous than the T FH cells in those primary cultures (Fig. 5a,b) . Thus, B cells suppressed by T FR cells were able to facilitate T FH cell population expansion after T FR cells were no longer present.
T FR cell suppression of B cells results in epigenetic changes
We also analyzed IgG1 in B cells from those secondary cultures. Suppressed B cells cultured with T FH cells were still severely defective in their ability to undergo CSR (Fig. 5c) . Although most cultures of suppressed B cells that were reactivated in secondary culture with T FH cells contained less secreted antibody than that of activated primary cultures, in some cases antibody could be found in these cultures (Supplementary Fig. 6 ), which suggested that a small population of B cells might have escaped suppression. Glycolysis was also defective after restimulation of the suppressed B cells; Glut1 expression was lower in suppressed B cells that were reactivated in secondary culture with T FH cells than in activated B cells from primary cultures (Fig. 5d) . Additionally, the uptake of glucose was much lower by suppressed B cell secondary cultures than by activated primary cultures (Fig. 5e) . Together these data indicated that the B cells suppressed by T FR cells had defects in CSR and metabolism that continued in the absence of continued contact with T FR cells.
To investigate whether the durable defects in the effector function and metabolism of B cells might have been caused by epigenetic changes enforced by T FR cells during suppression, we assessed chromatin accessibility by assay for transposase-accessible chromatin with high-throughput sequencing (ATAC-seq). Comparison of activated B cells versus suppressed B cells, both from primary cultures, revealed 2,334 genes with evidence of less accessibility in the suppressed B cell condition (Fig. 5f) . Of those genes, 114 also had lower expression by RNA-seq analysis (Fig. 5g) . Genes encoding B cell functional proteins and upstream regulators of metabolism, such as Aicda, Myc and Pou2af1, showed evidence of chromatin inaccessibility in the suppressed condition (Fig. 5g) , suggestive of epigenetic modification.
To explore how the genes identified above might be regulated, we overlaid our ATAC-seq data with the 'B cell regulome' (a collection of confirmed interactions of promoters with long-range enhancers in B cells) defined by ChIA-pet techniques 33 . The Aicda locus showed less accessibility in suppressed B cells than in activated B cells in two regions, one ~8 kilobases (kb) and another ~21 kb upstream of the Aicda transcriptional start site (TSS) (Fig. 5h) . These enhancer A r t i c l e s regions are essential for AID expression 33, 34 . We identified seven putative enhancer regions in the Myc locus that were less accessible in B cells suppressed by T FR cells than in activated B cells (Fig. 5i) . We found one peak that was less accessible in the Pou2af1 locus that was located in an intronic region in between exon 1 and exon 2 (Fig. 5j) . We noticed that many of the less-accessible regions in suppressed B cells were not at the TSS but were at sites of long-range enhancers (Fig. 5h-j) . When we quantified the distribution of all ATAC-seq regions relative to the location of the TSS, we found that less-accessible regions in B cells suppressed by T FR cells tended to be further away from the TSS than were all regions identified by ATACseq (Fig. 5k) . These data indicated that genes encoding products critical for B cell function, but not those encoding key metabolic enzymes, showed evidence of epigenetic regulation during suppression by T FR cells.
IL-21 can overcome T FR cell-mediated suppression of B cells
We investigated whether IL-21 was able to overcome the suppression of B cells by T FR cells because IL-21 is essential in the GC reaction, is suppressed by T FR cells, can coordinate lipid and glucose metabolism in fat tissue and can inhibit T reg cells 35, 36 . The addition of IL-21 to suppression cultures 'rescued' the attenuation of B cell proliferation and CSR by T FR cells (Fig. 6a,b) . IL-21 and IL-6, but not IL-4, restored the secretion of IgG by cultures with T FR cells (Fig. 6c) .
The restoration of CSR by IL-21 and IL-6 was not due to enhanced proliferation (Supplementary Fig. 7) . We reasoned that if IL-21 were able to restore antibody production, it would also 'rescue' defects in metabolism during suppression by T FR cells, since our studies showed that metabolism and B cell function were interconnected. Glut1 expression was restored in both B cells and T FH cells when IL-21 was added to cultures containing T FR cells (Fig. 6d and data not shown) . Moreover, IL-21 restored glucose uptake (Fig. 6e) , and both IL-21 and IL-6 increased lactate production in cultures with T FR cells (Fig. 6f) . The 'rescue' by IL-21 required glycolysis, as 2DG completely prevented the restoration of antibody production by IL-21 in suppressed cultures (Fig. 6g) . Therefore, IL-21 rendered B cells resistant to T FR cell-mediated suppression at least in part by enhancing glycolysis.
To identify which B cell transcripts were 'rescued' by IL-21, we performed RNA-seq analysis of B cells from activated cultures (T FH  cells (Fig. 6h) . Only 12 genes were expressed differentially in B cells from suppressed cultures versus those from 'IL-21 rescue' cultures and also in B cells from suppressed cultures versus those from activated cultures, and of these genes, only Ighg1 and Ighg2c were 'rescued' with IL-21 ( Fig. 6i and Supplementary Fig. 7) . Metabolic pathways such as Myc, glycolysis and oxidative phosphorylation showed evidence of some restoration by IL-21 (Fig. 6j) .
We next determined whether IL-21 restored antibody production by acting directly on B cells. For this, we performed suppression assays using B cells lacking the receptor for IL-21 (Il21r −/− ). Although baseline antibody responses were lower in cultures of Il21r −/− B cells with T FH cells than in those of Il21r +/+ B cells with T FH cells, we found no evidence that antibody responses were restored in suppressed cultures by the addition of IL-21 (Fig. 7a) . Loss of IL-21R did not abolish the increase in the number of B cells observed in suppressed cultures after the addition of IL-21 but did prevent the restoration of CSR and Glut1 expression (Supplementary Fig. 7 ). Since upregulation of GL7 is a robust indicator of B cell activation, we compared its expression in suppressed cultures containing either Il21r +/+ B cells or Il21r −/− B cells and supplemented with IL-21. IL-21 restored GL7 expression when Il21r +/+ B cells were present but not when Il21r −/− B cells were present (Fig. 7b,c) , which suggested that signaling through IL-21 into the B cells was essential for the restoration of B cell activation.
To investigate if IL-21 also affected T FR cells in the cultures, we compared T FR cells from the various cultures noted above. T FR cells expressed much less Ki67 in the presence of IL-21 than in its absence, and there were significantly fewer T FR cells in suppressed cultures with IL-21 than in those without it (Fig. 7d,e) ; this suggested that IL-21 inhibited the cell cycling of T FR cells. Glut1 expression was higher in T FR cells in the presence of IL-21 than in its absence (Fig. 7f) 37, 40 , was lower in suppressed T FH cells than in activated T FH cells. Suppressed B cells had minimal changes in the expression of genes encoding effector B cell molecules. However, the genes that were attenuated during suppression encode proteins with important roles in effector B cell function, including Pou2af1 (ref. 19) and AID. The suppressed B cells might have been arrested in a state of late activation, since genes encoding the late-activation and GC B cell transcription factors Pax5, Bach2 and Irf8 had higher expression after suppression.
The most substantial change in suppressed B cells was lower expression of genes encoding products involved in multiple metabolic pathways, including glycolysis, glutaminolysis, one-carbon metabolism, serine biosynthesis and purine biosynthesis, as well as their upstream mediators Myc and mTOR. It is unclear if T FR cells prevented their upregulation or actively downregulated genes encoding components of these pathways. Our findings are consistent with published work showing that the activation of B cells induces glycolysis in B cells, which might aid in antibody production 31, 41 . Glycolysis and the mTOR pathway were also inhibited in T FH cells suppressed by T FR cells. Glycolysis and the mTOR pathway can inhibit T FH cell differentiation 42 , but our work indicated that these pathways also might be important for the effector function of T FH cells.
Our 48 . Il21r −/− mice on the C57Bl/6 background were from the Kuchroo Lab. Actin CFP Foxp3 GFP mice on the C57Bl/6 background have been published previously 12 . All mice were between 6 and 8 weeks of age at the time of experiments and were housed in a SPF facility. Each individual experiment contained one sex of mice, but replicates were performed with males or females. All mice were used according to the Harvard Medical School Standing Committee on Animals and National Institutes of Health Guidelines.
Immunization. Mice were immunized with 100 µg NP-OVA (Biosearch Technologies) emulsified in H37RA CFA s.c. in the mouse flanks as previously described 12, 16 . Mice were sacrificed 7 d later and inguinal lymph nodes were harvested. . In some cases, an alternative gating strategy was used; T FH (CD4 + ICOS + CXCR5 + GITR − CD1 9 − ), T FR (CD4 + ICOS + CXCR5 + GITR + CD19 − ) as previously described 12, 13 . B cells were isolated from flow-through from CD4 + selection, which was then positively selected using CD19 beads (Miltenyi Biotec). For wild-type versus Igh-Myc B cells, B cells were enriched with magnetic selection and then sorted as CD19 + GL7 − cells to rule out effects of spontaneous activation in Igh-Myc mice.
Suppression assay.
In vitro suppression assays were performed as described previously 12, 14, 16 . Foxp3 GFP reporter mice were immunized with NP-OVA, and suppressed B cells (or freshly isolated B cells) were then cultured with freshly isolated 3 × 10 4 T FH cells, prepared as above, in the presence of anti-CD3 and IgM. In some studies, small-molecule compounds were added to cultures: Myc inhibitor 10058-F4 (100 µM), mTOR inhibitors rapamycin (10 nM) and PP242 (200 nM), methotrexate (1 µM), azathioprine (50 µM) (all from Tocris Bioscience), the glycolysis inhibitor 2-deoxyglucose (2DG; 500 µM) and the glutaminolysis inhibitor BPTES (8 µM) (both from Sigma). In some experiments, recombinant IL-21, IL-4 or IL-6 (Peprotech) were added to wells (at 60-90 ng/ml).
RNA-seq. Samples were sorted as described above, and each replicate indicates a biological replicate that was prepared using different sets of mice on different experimental days. RNA-seq libraries were prepared (N.C. data not shown). RNA was isolated using MyOne Silane Dynabeads (Thermo Fisher Scientific). RNA was fragmented and then was bar-coded using 8-bp barcodes in conjunction with standard Illumina adaptors. Primers were removed using Agencourt AMPure XP bead cleanup (Beckman Coulter/Agencourt) and samples were amplified with 14 PCR cycles. Libraries were gel purified and quantified using a Qubit high sensitivity DNA kit (Invitrogen) and library quality was confirmed using Tapestation high sensitivity DNA tapes (Agilent Technologies). RNA-seq reactions were sequenced on an Illumina HiSeq 2000 or Illumina NextSeq sequencer (Illumina) according to the manufacturer's instructions, sequencing 50-bp reads. Analysis was performed using the CLC Genomics Workbench version 8.0.1 RNA-seq analysis software package (Qiagen). Reads were aligned (mismatch cost = 2, insertion cost = 3, deletion cost = 3, length fraction = 0.8, similarity fraction = 0.8) to the mouse genome and differential expression analysis was performed (total count filter cutoff = 5.0). Results were normalized to reads per million. Gene-e (Broad Institute) was used to generate heat maps. ATAC-seq. 5 × 10 4 sorted cells per biological replicate were washed once in cold PBS and lysed in 50 µl cold lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl 2 and 0.1% IGEPAL CA-630). Lysed nuclei were incubated in Tn5 transposition reaction mix as described 49 and purified using MinElute Reaction Cleanup kit (Qiagen). ATAC-seq fragments were size-selected for fragments between 115 and 600 bp using Pippin Prep 2% Agarose Gel Cassettes and the Pippin Prep DNA Size Selection System (Sage Science). Post size-selection, ATAC libraries were amplified and Nextera sequencing primers ligated using Polymerase Chain Reaction (PCR). Finally, PCR primers were removed using Agencourt AMPure XP bead cleanup (Beckman Coulter/Agencourt) and library quality was verified using a Tapestation machine. Samples were sequenced on an Illumina NextSeq sequencer. Peak calling and analysis was performed using CLC Genomics Workbench 8.0.1 ChipSeq analysis software (Qiagen) by combining all samples (maximum P value for peak calling = 0.05). Gene-peak associations were determined using the GREAT software package using the basal extension method 50 . Visualization was performed using Integrated Genomics Viewer (Broad Institute) using the mm10 mouse genome build. Gene tracks were annotated with previously published ChIA-pet gene-enhancer associations in B cells 33 .
Microscopy.
In vitro suppression assays were performed as above except B cells were pre-labeled with eFluor 670 proliferation dye (eBioscience) and cells were cultured in cytek imaging chambers coated with celltak (VWR). After 4 d of culture, CellMask Orange (Thermo Fisher Scientific) was added to the imaging chambers to detect membrane of B cells, T FH cells and T FR cells. Samples were imaged on a Nikon spinning-=disk confocal microscope using a 40× objective and standard lasers and filters. The z-stacks were converted to projections using ImageJ software. B cells were identified as blue (eFluor 670) and red (CellMask Orange), T FR cells were identified as green (Foxp3 IRES-GFP ) and red (CellMask Orange), and T FH cells were identified as red (CellMask Orange). Supplementary Video 1 is representative of imaging studies repeated for three independent biological replicates.
IgH sequencing. B cells were sorted from suppression assays as above, and IgH sequencing was performed using the Adaptive Biotechnologies ImmunoSeq mouse IgH sequencing platform (Adaptive Biotechnologies).
GSEA. For GSEA analysis, RNA-seq data were converted to human nomenclature and compared to GSEA mSigDatabases including Hallmarks, C3 and C5 collections using standard settings (Broad Institute). For enrichment plots of specific gene sets, pathways were analyzed along with 20 randomized gene sets to ensure specificity. Single sample GSEA was performed in GenePattern using indicated gene sets (Broad Institute).
ELISA. ELISA measurements of total IgG from culture supernatants were performed as described previously 12, 16 .
Statistics. Most statistical tests were performed using Prism 6.0 (GraphPad) using Student's two-tailed unpaired t-test or one-way ANOVA with Tukey's correction as specified assuming Gaussian distribution. Statistics for RNA-seq and ATAC-seq were performed using CLC Genomics Workbench (Qiagen).
Statistics for gene-set enrichment was performed in GSEA (Broad Institute). Statistics for Volcano plots were performed in Microsoft excel using a χ 2 test. Samples were not randomized and investigators were not blinded to sample identity, and there was no exclusion of data. Sample sizes were chosen as the minimum number of mice (typically 20) to sort enough cells to perform three to four technical replicate stimulation or suppression assays.
